LU AA 37096

Drug Profile

LU AA 37096

Alternative Names: Lu AA37096; LU-AA37096

Latest Information Update: 18 May 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Lundbeck A/S
  • Class Analgesics; Mood stabilisers
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Mood disorders; Pain

Most Recent Events

  • 03 Jan 2008 Phase-I clinical trials in Affective disorders in Denmark (unspecified route)
  • 03 Jan 2008 Phase-I clinical trials in Pain in Denmark (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top